Status:

COMPLETED

A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee

Lead Sponsor:

Pfizer

Conditions:

Osteoarthritis, Knee

Eligibility:

All Genders

35-75 years

Phase:

PHASE2

Brief Summary

To evaluate the safety and tolerability of single IV doses of PF-04383119 in Japanese patients with moderate to severe pain from OA of the knee (Part I). To evaluate the preliminary analgesic efficacy...

Eligibility Criteria

Inclusion

  • Japanese Male or female, Age 35-65 (Part 1), Age 35-75 (Part 2)
  • Diagnosis of osteoarthritis (OA) of the knee based on American College of Rheumatology criteria
  • Knee pain, and radiographic evidence of knee OA (Kellgren-Lawrence x-ray grade ≥2) obtained within 1 year of enrollment
  • At least one of the following: age \>50, morning stiffness \<30 minutes in duration, crepitus, and OA of the knee must involve the index tibiofemoral joint and must have present for at least 6 months
  • Patients who meet at least one of the following: unwilling to take non-opiate pain medications, or for whom non-opiate pain medications have failed, or are candidates for or seeking invasive interventions such as intraarticular injections, knee arthroplasty, or total knee surgery
  • Pain levels as required by the protocol at Screening and Baseline

Exclusion

  • Diagnosis or history of RA, any inflammatory arthritis, gout, Paget's disease or any other disease that in the Investigator's opinion would interfere with the assessment of pain and other symptoms of OA
  • Patients with regional pain syndromes suggestive of fibromyalgia or regional pain caused by lumbar or cervical compressions with radiculopathy or at risk of developing radiculopathy.
  • Diagnosis or history of fibromyalgia
  • Planned surgical procedure during the duration of the study

Key Trial Info

Start Date :

June 6 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 25 2009

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT00669409

Start Date

June 6 2008

End Date

December 25 2009

Last Update

February 21 2021

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

National Hospital Organization Takasaki General Medical Center

Takasaki, Gunma, Japan, 370-0829

2

Fujisawa shounandai Hospital

Fujisawa-shi, Kanagawa, Japan, 252-0802

3

Nippon Kokan Clinic

Kawasaki, Kanagawa, Japan, 210-0852

4

Medical Corporation Yamamoto Kinenkai Yamamoto Kinen Hospital

Yokohama, Kanagawa, Japan, 224-0024

A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee | DecenTrialz